Logo image
Sign in
Thromboembolic Disorder in COVID-19 Infection
Journal article   Peer reviewed

Thromboembolic Disorder in COVID-19 Infection

Shawn Lee, Joseph Gunderson and Raza Mushtaq
Current Medical Imaging, Vol.19(14)
2023

Abstract

Blood Coagulation Disorders COVID-19 Humans SARS-CoV-2 anticoagulant agent D dimer fondaparinux heparan sulfate heparin interleukin 6 low molecular weight heparin nadroparin tumor necrosis factor receptor vascular cell adhesion molecule 1 von Willebrand factor China Clinical management Coagulation parameter Coagulopathy Coronaviruses Global data Pathophysiology Pulmonary complications Thromboembolic disorder activated partial thromboplastin time acute kidney failure adult respiratory distress syndrome anticoagulant therapy anticoagulation blood clotting disorder China complement activation complement deposition computed tomography pulmonary angiography computer assisted tomography coronavirus disease 2019 disseminated intravascular clotting gene mutation ground glass opacity hemodynamics histopathology hospitalization human imaging intensive care unit lung complication lung embolism lung infarction microvascular thrombosis middle cerebral artery mortality pandemic pathophysiology platelet count pneumonia proteinuria prothrombin time randomized controlled trial (topic) Review sepsis-associated coagulopathy Sequential Organ Failure Assessment Score Severe acute respiratory syndrome coronavirus 2 thorax pain thrombocytopenia thrombocytopoiesis thromboembolism venous thromboembolism blood clotting disorder Coronavirus

Metrics

1 Record Views

Details

Logo image